-Economic and Political Weekly The Indian weaver is dismissed in high places as an embarrassing anachronism, despite demand for his or her skills and products. In the new millennium, globalisation and a mindless acquiescence to imported notions of a good life threaten to take over, even as the West looks East for better concepts of sustainable living. Analysing today's crisis in the handloom sector, plagued by low-cost imitations from power looms,...
More »SEARCH RESULT
Mapping exclusion -Amit Thorat
-The Indian Express Three members of a Dalit family in Maharashtra's Ahmednagar were killed, one of them decapitated before being thrown into a dry well in Jawkhede Khalsa village, on the night of October 20. The investigation is still on and the jury out on whether it was an act of caste violence or the result of a dispute. In recent times, however, it seems there is a surge in the...
More »Dalits and nutrition: Where is the catch up? -Biraj Swain
-Down to Earth Blog The performance of nutrition indicators amongst Dalits is improving, it is nowhere near the catch-up pace Does a new government and a strong Prime Minister claiming to hail from the backward caste augur Achche Din for Dalits too? We hope so! But political commitment-or lack of it-has multiple manifestations. In a deeply stratified society like India with entrenched elitism, people from the Scheduled Caste (referred to as Dalits...
More »Database error: Why Delhi's failed experiment shows government should not use them -M Rajshekhar
-The Economic Times In the leaky system of welfare delivery, databases are the newest valve that governments are installing to ensure that benefits reach those-and only those -they are intended for. Since December 2012, for instance, the government of Madhya Pradesh has been appending on to the Centre's Socio Economic and Caste Census a host of household-level data: bank account numbers, NREGA card numbers, welfare entitlements, land ownership, whether their house is...
More »Ranbaxy fined $500 m for flawed generics-Narayan Lakshman
-The Hindu Ranbaxy, one of India's largest pharmaceutical companies, has agreed to pay $500 million fines levied by U.S. authorities for selling adulterated drugs and lying to federal regulators in a case that is part of an ongoing crackdown on the quality of generic drugs flowing into the U.S. The deal struck on Monday, said to be the largest financial penalty against a generic drug company for violations of FDA standards, came...
More »